The UK's Health Research Authority has released guidance on what researchers should tell patients at the conclusion of clinical trials and studies with a clinical intervention.
The guidance, published on 19 May, outlines the information that should be made available to patients at the end of a study, including what they can expect to happen to them and any requirements for ongoing monitoring of side effects.
The HRA also says that patients should be made of aware of how to access study results and how to opt out of the process if they would rather not see their findings.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.